Add BrightSurf on Google Email

Wisconsin scientists find a way to make human collagen in the lab

A team of scientists from the University of Wisconsin-Madison reports a breakthrough in making human collagen in the lab, opening doors for medical applications and nanotechnology. The new discovery enables the creation of synthetic collagen that can be tailored for specific uses, including wound healing and implantable sensors.

SourceUniversity of Wisconsin-Madison·JournalProceedings of the National Academy of Sciences·DateFeb 13, 2006

Study confirms that stents releasing medication help keep heart bypass vein grafts open

A new study published in Catheterization and Cardiovascular Interventions found that drug-eluting stents reduce the incidence of restenosis, heart attacks, and death by fourfold compared to conventional stents. Medicated stents were effective in keeping vein grafts open without affecting other parts of the bypass.

SourceCedars-Sinai Medical Center·JournalCatheterization and Cardiovascular Interventions·DateDec 1, 2005

Researchers prevent post-traumatic brain damage

Researchers have found that an experimental drug can effectively prevent much of the brain damage caused by traumatic injury. In a study using rat models, the drug was shown to reduce brain damage and improve cognitive and motor function. The breakthrough could potentially lead to new treatments for human traumatic brain injuries.

SourceGeorgetown University Medical Center·JournalProceedings of the National Academy of Sciences·DateMay 16, 2005

Crystals on a ball

Researchers have discovered that spherical crystals develop unique 'scar' defects to compensate for the curved surface, allowing them to pack in place. The findings, supported by experiments with water droplets and tiny beads, provide insights into how such structures form and persist in nature.

New avenue of HIV damage found

Researchers have found a new avenue of HIV damage that affects the structure of CD4 T cells, making it impossible for them to function normally. This discovery may lead to improved disease staging and therapy, as therapies targeting inflammation and scar tissue accumulation could enhance current antiviral treatment.

SourceUniversity of Minnesota·JournalJournal of Clinical Investigation·DateOct 9, 2002

Scarring process plays major role in kidney rejection following transplant, researchers report

A study by UCSD researchers reveals that chronic kidney rejection is caused by the recipient's own cells' normal reaction to a wound, specifically mesenchymal cells colonizing the transplant site. This finding opens up new possibilities for developing methods to block scar-causing cells and mitigate or prevent kidney rejection.

SourceUniversity of California - San Diego·JournalNew England Journal of Medicine·DateJul 11, 2001